Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oncology drugs
Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
By 2030, Daiichi envisions its revenues will reach more than 3 trillion yen ($19.1 billion), with 2.3 trillion yen from its oncology portfolio.
Angus Liu
May 11, 2026 10:22am
Pfizer's COVID franchise keeps guidance level after strong Q1
May 5, 2026 11:17am
Gates-backed TerraPower sketches out $450M radioisotope facility
Mar 18, 2026 10:40am
Lilly's Retevmo succeeds as adjuvant treatment in NSCLC
Feb 17, 2026 11:02am
Amgen gets some relief in Blincyto patent feud with Lindis
Aug 15, 2025 10:13am
Fierce Biotech
Karyopharm lays off 20% of staffers amid hunt for alternatives
Jul 11, 2025 11:02am
